Covishield

Serum Institute Responds for First Time on Covishield Amid safety Row

by
Serum Institute Responds for First Time on Covishield Amid safety Row

Amid the concerns about Thrombosis with Thrombocytopenia Syndrome (TTS), a rare side-effect caused by the AstraZeneca’s Covid-19 vaccine sold as Covishield in India, the Serum Institute of India (SII), which manufactured the drug, stated that all its product packaging had disclosed all “rare” to “very rare side-effects”, including TTS. “We fully understand the ongoing concerns … Read more

Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern

by
SC Blast IMA Chief in Patanjali Ads Case

The Supreme Court will hear a petition on a rare side-effect associated with the COVID-19 vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold, in this country, as Covishield.  A date for the hearing has not been set but Chief Justice DY Chandrachud acknowledged … Read more